Topics
April 2016 | Cover Focus: Advances In Retina Medicine
A Primer on Cellular Therapy
The treatment approach has taken aim at its first retinal disease: CMV retinitis.
Mrinali Gupta, MD, and Szilá,rd Kiss, MD
May 5, 2026
Viridian Therapeutics Reports Positive Phase 3 Results for Thyroid Eye Disease Drug
Oculis Highlights New Global Consensus on Diabetic Macular Edema Care at ARVO
May 4, 2026
Johnson & Johnson Showcases New Vision Research at ARVO 2026
Lineage Cell Therapeutics Reports 36-Month Data for OpRegen in Geographic Atrophy
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
